XML 51 R18.htm IDEA: XBRL DOCUMENT v3.25.1
Accrued Expenses and Other Current Liabilities
 12 Months Ended
Dec. 31, 2024
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consist of the following (in thousands):
December 31,
20242023
Compensation, bonuses, and related benefits$4,235 $3,496 
Research and development5,047 4,895 
Accrued severance, bonus, and retention (1)
107 2,476 
Accrued offering costs in connection with pre-closing financing— 3,334 
Accrued transaction costs related to reverse merger— 2,557 
Other342 737 
Total accrued expenses and other current liabilities$9,731 $17,495 
(1) For the year ended December 31, 2023 accrued expenses includes accrued severance, bonus, and retention payments for current and former Neoleukin employees. Refer to Note 10, Commitments and Contingencies, for further detail.